Pharma Reviews: Pharma Woes Axe $14 Billion From Wealth of Once-Richest Indian

(Bloomberg) -- Dilip Shanghvi's shrinking fortune has become one of the most visible casualties of the troubles hitting India's generic drug industry.
Read more: Pharma Woes Axe $14 Billion From Wealth of Once-Richest Indian